Cardiology association calls for DES (drug-eluting stent) reimbursement in Germany
This article was originally published in Clinica
Executive Summary
Drug-eluting stents (DESs) are undeniably more expensive than bare stents, but in the long-term they could save the German health service money by preventing the re-hospitalisation of patients and avoiding re-intervention, says the German Cardiology Association (DKG).